Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Top Cited Papers
Open Access
- 1 January 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (1), 471-478
- https://doi.org/10.1074/jbc.m209423200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent PathwayJournal of Biological Chemistry, 2000
- Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic ratsJournal of Clinical Investigation, 2000
- Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.Journal of Clinical Investigation, 1998
- Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.Journal of Clinical Investigation, 1997
- PACAP Type I Receptor Activation Promotes Cerebellar Neuron Survival Through the cAMP/PKA Signaling PathwayDNA and Cell Biology, 1997
- Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in manDigestive Diseases and Sciences, 1993
- Differences in aggregation properties and levels of the neural cell adhesion molecule (NCAM) between islet cell typesExperimental Cell Research, 1990
- Truncated glucagon‐like peptide‐1 (proglucagon 78–107 amide), an intestinal insulin‐releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH)FEBS Letters, 1988
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.Journal of Clinical Investigation, 1987